Interestingly, in one study, CRISPR/Cas9 system has been applied to knock out SIRP-α in macrophages and subsequently enhanced the ability of macrophages to phagocytose cancer cells which providing a new immunotherapeutic method for cancer therapy (18). The gene discussed is SIRPA; the disease is cancer.